XTAENXFR
Market cap2mUSD
Dec 20, Last price
126.10ILS
1D
-3.89%
1Q
563.68%
IPO
-89.97%
Name
Nextferm Technologies Ltd
Chart & Performance
P/E
—
P/S
763.36
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
110.34%
Rev. gr., 5y
%
Revenues
283k
+8.02%
Net income
-4m
L-47.27%
CFO
-4m
L-50.22%
Profile
NextFerm Technologies Ltd, a food-tech company, engages in the research, development, and marketing of yeast-based technologies and products without genetic engineering for the food industry. It offers Astaferm, a fermented-astaxanthin; NextFreeze, a yeast product to better resist multiple freeze thaw cycles; Biofuel, a novel yeast strain for more efficient production of ethanol from corn Mesh; and ProteVin, a vegan protein. The company was incorporated in 2013 and is headquartered in Yokneam Illit, Israel.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | 283 8.02% | 262 8.26% | 242 154.74% | ||||
Cost of revenue | 4,727 | 8,427 | 4,749 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (4,444) | (8,165) | (4,507) | ||||
NOPBT Margin | |||||||
Operating Taxes | 1,000 | 7 | 2 | ||||
Tax Rate | |||||||
NOPAT | (4,445) | (8,172) | (4,509) | ||||
Net income | (4,254) -47.27% | (8,068) 46.50% | (5,507) 36.92% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 56,996 | ||||||
BB yield | -63.08% | ||||||
| Debt | |||||||
Debt current | 681 | 666 | |||||
Long-term debt | 482 | 783 | 1,126 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 240 | 314 | 347 | ||||
Net debt | (2,799) | (1,719) | (11,512) | ||||
| Cash flow | |||||||
Cash from operating activities | (3,800) | (7,633) | (3,823) | ||||
CAPEX | (895) | (2,159) | (1,259) | ||||
Cash from investing activities | (716) | (2,159) | (1,259) | ||||
Cash from financing activities | 4,813 | (212) | 17,504 | ||||
FCF | (4,187) | (8,360) | (7,844) | ||||
| Balance | |||||||
Cash | 3,281 | 3,024 | 13,164 | ||||
Long term investments | 159 | 140 | |||||
Excess cash | 3,267 | 3,170 | 13,292 | ||||
Stockholders' equity | (31,434) | 84,135 | 78,589 | ||||
Invested Capital | 36,831 | 2,167 | (149) | ||||
ROIC | 459.97% | ||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 68,165 | 15,057 | 11,154 | ||||
Price | 0.24 -74.53% | 0.95 -88.27% | 8.10 | ||||
Market cap | 16,496 15.32% | 14,304 -84.17% | 90,350 | ||||
EV | 13,697 | 12,586 | 78,838 | ||||
EBITDA | (3,966) | (7,780) | (4,270) | ||||
EV/EBITDA | |||||||
Interest | 383 | 443 | |||||
Interest/NOPBT | |||||||